From: Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
HC (n = 50) M (SD) | ME/CFS (n = 50) M (SD) | Post-COVID (n = 87) M(SD) | Statistics | Bonferroni (p) | |||
---|---|---|---|---|---|---|---|
ME/CFS vs post-COVID | ME/CFS vs HC | Post-COVID vs HC | |||||
Age, years | 42.3 (9.9) | 44.1 (8.5) | 45.6 (9.4) | H = 3.6 | |||
Education, years | 16.7 (2.5) | 14.59 (4.1) | 16.3 (3.3) | H = 10.7** | 0.042 | 0.004 | |
Female, n (%) | 40 (80.0) | 45 (90.0) | 62 (71.3) | χ2 = 6.7* | |||
Disease duration, months | – | 52.4 (50.4) | 13.7 (6.9) | U = 3696.0*** | |||
COMPASS 31 | 3.8 (4.6) | 25.4 (10.5) | 19.6 (8.9) | H = 96.2*** | 0.039 | < 0.001 | < 0.001 |
SFNSL | 2.1 (3.4) | 34.7 (15.7) | 26.6 (14.4) | H = 96.8*** | < 0.001 | < 0.001 | |
Karnofsky scale | 99.0 (3.6) | 68.9 (8.8) | 73.1 (8.4) | H = 118.4*** | < 0.001 | < 0.001 | |
SF-36 | 85.7 (9.7) | 29.1 (15.0) | 40.4 (17.0) | H = 108.5*** | 0.016 | < 0.001 | < 0.001 |
MFIS | 10.5 (11.8) | 68.1 (12.8) | 63.4 (15.2) | H = 106.8*** | < 0.001 | < 0.001 | |
PSQI | 5.1 (3.0) | 12.6 (5.0) | 10.7 (4.5) | H = 59.2*** | < 0.001 | < 0.001 | |
STAI-State | 11.9 (10.2) | 30.2 (16.0) | 27.3 (13.9) | H = 44.9*** | < 0.001 | < 0.001 | |
STAI-Trait | 13.0 (9.4) | 24.6 (16.0) | 16.4 (13.6) | H = 14.7*** | 0.007 | 0.001 | |
GDS | 1.1 (11.5) | 9.3 (3.4) | 7.0 (3.8) | H = 95.1*** | 0.025 | < 0.001 | < 0.001 |
C-SSRS | 0.0 (0.0) | 1.2 (1.9) | 0.2 (0.5) | H = 34.1*** | < 0.001 | < 0.001 |